This article talks about a news "Scientists Find Missing Cell Division Switch—And a New Way to Fight Cancer".

When a cell gets ready to split, it hits the pause button on reading its own genes. Cell division is a huge logistical task, and it needs every bit of focus on packing up its dna and dividing it evenly.

For a long time, scientists couldn't quite figure out how cells pull of this rapid shutdown. But a new study out of yale school of medicine, published in molecular cell , just filled in major missing piece of the puzzle.

The double life of METTL3

At the center of this discovery is an enzyme called METTL3.

For years, ressearchers knew it primarily for placing tiny chemical tags on messenger RNA (mRNA) to dictate whether those strands get used , stored, or recycled.

However, co-lead researcher claudio R. Alarcon and his team previously discovered that METTL3 has side job: it actually helps control how mRNS gets produced in the first place. It does this by tagging a specific scaffold RNA named 7SK. Normally, 7SK acts like a tiny sponge that traps key proteins required to read genes.

When METTL3 tags 7SK, the trap opens, releasing those proteins so the cell can start making all components it needs to grow.

Clearing the track for division

What this new study shows is that the exact same mechanism gets flipped when a cell commits to dividing.

1. The signal: An enzyme called CDK1 turns METTL3 on.
2. The Sweep: METTL3 triggers the release mechanism, but this time, the goal isn't to build new proteins, instead it finished up active gene reading tasks and clears remaining RNA molecules off the chromosomes.
3. The pack: Stripping away the RNA frees up the DNA so it can tightly condense and split apart without getting tangled.

As co-lead author Lilian Kabeche explains, mitosis only takes about an hour.

This is because the window is so tight, DFK1 acts like a precision light switch turning METTL3 on to clear the DNA , then switching off once division wraps up so normal functions can resume later.

What happens when it fails?

To see how crucial this pathaway is, the researchers used CRISPR to block CDK1 from activating METTL3. Without that signal , the cell's division process fell apart.

This chromosomes got left behind , didn't split correctly, and picked up genetic mutation.

This miscount of chromosomes-a state called aneuploidy is a hallmark of cancer.

It shows up in over 90% of solid tumors and makes cancer far more aggressive, drug resistant, and prone to spreading.

A new target for cancel therapy

Since cancel cells already suffer from high chromosomal instability, kabeche points out that pushing them just a little bitfurther over the edge can cause them to collapse completely. Existing METTL3 inhibitor durgs could potentially be paired with other treatments to overload tumor cells past their breaking point.

Becauyse most previcious research on METTL3 only looked at its secondary role in managing mRNA stability, this new link directly to how the cell division works opens up a whole new angle for targeted cancer therapies.

Scientists mentioned in this article

Source: Hidden Switch in Cell Division May Point to New Cancer Treatments